BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 14530185)

  • 1. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Juhani Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(14):1664-72. PubMed ID: 14530185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research.
    Gaba P; Gersh BJ; Muller J; Narula J; Stone GW
    Nat Rev Cardiol; 2023 Mar; 20(3):181-196. PubMed ID: 36151312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(15):1772-8. PubMed ID: 14557340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of the vulnerable plaque.
    Virmani R; Burke AP; Farb A; Kolodgie FD
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C13-8. PubMed ID: 16631505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective natural-history study of coronary atherosclerosis.
    Stone GW; Maehara A; Lansky AJ; de Bruyne B; Cristea E; Mintz GS; Mehran R; McPherson J; Farhat N; Marso SP; Parise H; Templin B; White R; Zhang Z; Serruys PW;
    N Engl J Med; 2011 Jan; 364(3):226-35. PubMed ID: 21247313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and plaque vulnerability.
    Hansson GK; Libby P; Tabas I
    J Intern Med; 2015 Nov; 278(5):483-93. PubMed ID: 26260307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concept of vulnerable/unstable plaque.
    Finn AV; Nakano M; Narula J; Kolodgie FD; Virmani R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1282-92. PubMed ID: 20554950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives.
    Stefanadis C; Antoniou CK; Tsiachris D; Pietri P
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314799
    [No Abstract]   [Full Text] [Related]  

  • 10. Individual and System Contributions to Race and Sex Disparities in Thrombolysis Use for Stroke Patients in the United States.
    Faigle R; Urrutia VC; Cooper LA; Gottesman RF
    Stroke; 2017 Apr; 48(4):990-997. PubMed ID: 28283607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.
    Conen D; Chae CU; Glynn RJ; Tedrow UB; Everett BM; Buring JE; Albert CM
    JAMA; 2011 May; 305(20):2080-7. PubMed ID: 21610240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of plaque formation and rupture.
    Bentzon JF; Otsuka F; Virmani R; Falk E
    Circ Res; 2014 Jun; 114(12):1852-66. PubMed ID: 24902970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome.
    Motoyama S; Sarai M; Harigaya H; Anno H; Inoue K; Hara T; Naruse H; Ishii J; Hishida H; Wong ND; Virmani R; Kondo T; Ozaki Y; Narula J
    J Am Coll Cardiol; 2009 Jun; 54(1):49-57. PubMed ID: 19555840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.
    van der Wal AC; Becker AE; van der Loos CM; Das PK
    Circulation; 1994 Jan; 89(1):36-44. PubMed ID: 8281670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond randomised versus observational studies.
    Concato J; Horwitz RI
    Lancet; 2004 May; 363(9422):1660-1. PubMed ID: 15158623
    [No Abstract]   [Full Text] [Related]  

  • 16. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
    Stary HC; Chandler AB; Dinsmore RE; Fuster V; Glagov S; Insull W; Rosenfeld ME; Schwartz CJ; Wagner WD; Wissler RW
    Circulation; 1995 Sep; 92(5):1355-74. PubMed ID: 7648691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulnerable Plaque, Characteristics, Detection, and Potential Therapies.
    Hafiane A
    J Cardiovasc Dev Dis; 2019 Jul; 6(3):. PubMed ID: 31357630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke.
    Spagnoli LG; Mauriello A; Sangiorgi G; Fratoni S; Bonanno E; Schwartz RS; Piepgras DG; Pistolese R; Ippoliti A; Holmes DR
    JAMA; 2004 Oct; 292(15):1845-52. PubMed ID: 15494582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requiem for the 'vulnerable plaque'.
    Libby P; Pasterkamp G
    Eur Heart J; 2015 Nov; 36(43):2984-7. PubMed ID: 26206212
    [No Abstract]   [Full Text] [Related]  

  • 20. The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.
    Arbab-Zadeh A; Fuster V
    J Am Coll Cardiol; 2015 Mar; 65(8):846-855. PubMed ID: 25601032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.